SGLT2 Inhibitors and Diabetic Kidney Disease: Targeting Multiple and Interrelated Signaling Pathways for Renal Protection.
第一作者:
Georgios,Papaetis
第一单位:
K.M.P THERAPIS Paphos Medical Center, Internal Medicine and Diabetes Clinic, 14 Vasileos Georgiou B Street, Office 201, 8010, Paphos, Cyprus.;CDA College, 73 Democratias Avenue, Paphos, Cyprus.
作者:
医学主题词
人类(Humans);糖尿病肾病(Diabetic Nephropathies);信号传导(Signal Transduction);糖尿病, 2型(Diabetes Mellitus, Type 2);动物(Animals);肾(Kidney);钠-葡萄糖转运体2(Sodium-Glucose Transporter 2);肾素-血管紧张素系统(Renin-Angiotensin System)
DOI
10.2174/0118761429261105231011101200
PMID
37904562
发布时间
2025-09-12
- 浏览0
Current molecular pharmacology
e18761429261105页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



